Navigation Links
China Cord Blood Corporation Acquires Stake in Shandong Cord Blood Bank
Date:2/24/2010

HONG KONG, Feb. 24 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation ("CCBC" or "the Company") (NYSE: CO), China's first and largest cord blood bank operator in terms of geographic coverage, today announced that as part of its nationwide expansion strategy, it has entered into an agreement to acquire an effective 19.92% equity interest in Shandong Cord Blood Bank ("SCBB") for US$20.5 million (equivalent to HK$159.36 million) in an all-cash transaction. The Company intends to use its available cash to fund the acquisition. For the year ended December 31, 2010, CCBC's equity interest in SCBB is expected to yield dividend income of US$1.04 million (approximately to RMB7.07 million).

SCBB holds the exclusive license to provide cord blood services to eastern China's affluent Shandong Province. Upon the completion of the transaction, CCBC will own an indirect 19.92% interest in SCBB and is entitled to the right of first refusal on future transfers of SCBB equity interest, allowing it to expand its position in the future.

In China, the government enforces a one-license-per-region policy for operating cord blood banks, and so far it has only granted six licenses nationwide. Of those six, the Company holds two (to operate in Beijing and Guangdong Province) and this acquisition grants access to the third. No other company holds more than one of the remaining licenses.

Ms. Tina Zheng, Chairperson and CEO, said, "We are very pleased about the SCBB acquisition, which marks an important milestone in our Company's development of a nationwide business. We are also very excited about the prospects of China's cord blood storage industry, given its unique business environment and the size of its addressable market. This strategic expansion will increase CCBC's competitive advantage by enlarging the size of our potential market to three provinces with over 2.1 million new births per annum, representing growth of 1.1 million new births per annum. This, in turn, is expected to further drive CCBC's business growth and reinforce our dominance in China. We will leverage our in-depth market knowledge, hospital resources and marketing experience from our Beijing and Guangdong operations to enhance the Shandong operation."

Ms. Zheng continued, "Through this acquisition, we will demonstrate to investors our distinct ability to deliver results. We believe a successful consolidation will place us in a strategically advantageous position and pave the way for future corporate developments and strategic alliances within China."

Audio Webcast

The Company will hold an audio webcast at 8:00 a.m. US ET / 9:00 p.m. HKT on Thursday, February 25, 2010 to give a brief overview of the Company's developments on the acquisition, followed by a question and answer session.

Interested parties may access the audio webcast by following the below link: http://phx.corporate-ir.net/playerlink.zhtml?c=206671&s=wm&e=2764714 . A replay of the webcast will be accessible two hours after the presentation and will remain available for a year at the same URL link above.

To participate in the question and answer session, please dial 1-718-354-1231 or 1-866-519-4004 for US callers or +852 2475-0994 for Hong Kong callers, conference access id: 58763462. Please dial-in 10 minutes before the question and answer session begins to ensure proper connection.

About China Cord Blood Corporation

China Cord Blood Corporation is the first and the largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with more than one license (i.e., Beijing and Guangdong). Under the current PRC government regulations, only one licensed cord blood bank operator is permitted to operate in each licensed region and only six licenses has been issued as of today. China Cord Blood Corporation provides cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services. For more information about China Cord Blood Corporation, please visit: http://www.chinacordbloodcorp.com .

Forward-looking Statements

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the progress of new product development. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in the People's Republic of China, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.

    For more information, please contact:

     China Cord Blood Corporation
     Ms. Joe-ling Law
     Phone: +852-3605-8180
     Email: ir@chinacordbloodcorp.com

    ICR, Inc.

    In the United States:
     Ashley M. Ammon
     Phone: +1-646-277-1227

     Christine Duan
     Phone: +1-203-682-8200

    In China:
     Wei-Jung Yang
     Phone: +86-10-6599-7968

SOURCE China Cord Blood Corporation

Back to top
'/>"/>
SOURCE China Cord Blood Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. The 32nd Annual Los Angeles Chinatown Firecracker 5K/10K Run, Bike Ride, and Nite N Day Festival Celebrates the Year of the Tiger This Weekend
2. New Multivitamins Target Concern Over China's Quality Problems
3. Media, small businesses invited to ACS Webinar on ways to take advantage of Chinas dynamic growth
4. GNC Announces Entry to Chinas Nutritional Products in Partnership with Bright Food
5. Spine Surgeon from China Visits Panorama Orthopedics & Spine Center
6. China Cord Blood Corporation Warrant Registration Statement Declared Effective by SEC
7. MIT China joint venture is preparing a major commercial launch in July 2010
8. Major milestone achieved by our joint venture in China
9. Jion Beijing Great Wall International Travel Agency Immediate Exposure to China Expo 2010
10. China Sky One Medical, Inc. Featured by Science and Technology Daily
11. Significant urban-rural disparities in injury mortality seen in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... , ... December 09, 2016 , ... ... at The Pierre Hotel in New York, NY, on December 3rd, to benefit ... and physicians attended the annual event, which raised over $1 million - the ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital Tampa ... Hyperbaric Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies ... few hospitals and facilities have earned this distinction. This is the second time ...
(Date:12/8/2016)... ... 2016 , ... Mirixa Corporation , a leading healthcare ... patient care services, has announced the promotions of Karen Litsinger to senior vice ... sales. , Litsinger joined Mirixa in 2008 after serving as a partner ...
(Date:12/8/2016)... Tampa, Fla (PRWEB) , ... December 08, 2016 ... ... offering smarter modes of access for customers and employees that are both engaging ... ChangeGear 7 with Service Smart Technology, the software company revealed today its plans ...
(Date:12/8/2016)... Cambridge, MA (PRWEB) , ... December 08, 2016 , ... ... decreases in medical payments per workers’ compensation claim in 2013 and 2014, according to ... Workers Compensation Research Institute (WCRI) . , According to the study, medical payments per ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... VIEW, Calif. , Dec. 8, 2016 IRIDEX ... intends to offer newly issued shares of common stock, $0.01 ... pursuant to an underwritten public offering.  The final terms of ... the time of pricing, and there can be no assurance ... IRIDEX expects to use the net proceeds it ...
(Date:12/8/2016)... Australia Glaucoma Surgery Devices Market Outlook ... "Australia Glaucoma Surgery Devices Market Outlook to 2022", ... Surgery Devices market. The report provides value, in ... average prices (USD) within market segement - Glaucoma ... shares and distribution shares data for each of ...
(Date:12/8/2016)... -- The global biosurgery market is expected to grow at ... 2016 to 2021. The market is poised to reach ... in 2016. The market is primarily driven by rising ... and spinal problems, increasing clearance of biosurgery products by ... management. In this report, the biosurgery market ...
Breaking Medicine Technology: